Cubosomes and its Pharmaceutical Application in Treatment of Cancer

Cubosomes are lipid-based nanoparticles that have recently gained attention in the field of pharmaceuticals due to their unique physicochemical properties. These nanoparticles are composed of a highly ordered lipid bilayer that forms a cubic liquid crystalline phase, which can encapsulate both hydrophilic and hydrophobic drugs. The unique structure of cubosomes allows for high drug loading and sustained release, making them an attractive option for drug delivery. Cancer treatment is a major focus of research for cubosomes due to their potential for targeted drug delivery. Cubosomes have been shown to be effective in delivering chemotherapeutic agents to cancer cells, increasing drug efficacy while reducing toxicity to healthy tissues. Additionally, the highly ordered structure of cubosomes can be tailored to increase cellular uptake and improve the stability of the drug within the body.Recent studies have demonstrated the potential of cubosomes as an effective drug delivery system for a wide range of anticancer agents, including small molecule drugs, peptides, and nucleic acids. In addition, cubosomes have been explored for use in combination therapy, where multiple drugs can be encapsulated within a single nanoparticle. Overall, cubosomes have shown great promise as a versatile and effective drug delivery system for the treatment of cancer. Further research is needed to fully understand the potential of cubosomes in cancer therapy, including optimization of their structure, improved drug loading efficiency, and increased specificity for cancer cells